Literature DB >> 28578172

Major postoperative complications following surgical procedures for pelvic organ prolapse: a secondary database analysis of the American College of Surgeons National Surgical Quality Improvement Program.

Elisabeth Erekson1, Regan L Murchison2, Kristen A Gerjevic2, Vivienne T Meljen3, Kris Strohbehn2.   

Abstract

BACKGROUND: Surgical approaches to the correction of pelvic organ prolapse include abdominal, vaginal, and obliterative approaches. These approaches require vastly different anatomical dissections, surgical techniques, and operative times and are often selected by the patient and surgeon to match preoperative multimorbidity and ability of the patient to tolerate the stress of surgery.
OBJECTIVE: We sought to describe the occurrence of postoperative complications occurring after 3 different surgical approaches to treat pelvic organ prolapse: vaginal, abdominal, and obliterative. STUDY
DESIGN: We conducted a secondary database analysis of the 2006 through 2014 American College of Surgeons National Surgical Quality Improvement Program participant use data files to analyze patients undergoing procedures for pelvic organ prolapse based on Current Procedural Terminology codes. Women were categorized into 3 surgical approaches to prolapse: vaginal, abdominal, and obliterative. Concomitant hysterectomy and sling were also examined. The primary outcome was a composite of 30-day major postoperative complications.
RESULTS: A total of 33,416 women were included in our final analysis: 24,928 vaginal procedures, 6834 abdominal (4461 minimally invasive) procedures, and 1654 obliterative procedures. Concomitant hysterectomies and slings were performed in 17,380 (52.0%) and 10,896 (32.6%) of prolapse procedures. The overall prevalence of composite 30-day major postoperative complications was 3.1% (n/N = 1028/33,416). There were 13 perioperative deaths (0.04%) with no difference in the surgical approaches (P = .55). There were no differences in major postoperative complications between vaginal and abdominal procedures (3.0% vs 3.0%; P = .71). Women undergoing obliterative procedures had an occurrence of major postoperative complications of 5.0% (n/N = 83/1654), P < .001.
CONCLUSION: The occurrence of major postoperative complications after prolapse surgery is rare. We did not find a significant difference in major postoperative complications between vaginal and abdominal surgeries for pelvic organ prolapse. In this well-characterized cohort of patients who self-selected surgical approach, women undergoing obliterative surgery had more postoperative complications, likely attributed to increased age and multimorbidity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hysterectomy; pelvic organ prolapse; postoperative complications; sling; surgical site infection

Mesh:

Year:  2017        PMID: 28578172     DOI: 10.1016/j.ajog.2017.05.052

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Should we combine vaginal prolapse surgery with continence surgery?

Authors:  J Marinus van der Ploeg; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2018-11-08       Impact factor: 2.894

2.  Incidence and contributing factors of perioperative complications in surgical procedures for pelvic organ prolapse.

Authors:  Hanan Alshankiti; Sara Houlihan; Magali Robert
Journal:  Int Urogynecol J       Date:  2019-01-21       Impact factor: 2.894

3.  Effects of Pharmacologic Venous Thromboembolism Prophylaxis in Benign Hysterectomy.

Authors:  Jennifer Travieso; Neil Kamdar; Daniel M Morgan; Sawsan As-Sanie; Sara R Till
Journal:  J Minim Invasive Gynecol       Date:  2022-02-26       Impact factor: 4.314

4.  The Design of a Prospective Trial to Evaluate the Role of Preoperative Frailty Assessment in Older Women Undergoing Surgery for the Treatment of Pelvic Organ Prolapse: The FASt Supplemental Trial.

Authors:  Elisabeth Erekson; Shawn Menefee; Ryan E Whitworth; Cindy L Amundsen; Lily A Arya; Yuko M Komesu; Cecile A Ferrando; Halina M Zyczynski; Vivian W Sung; David D Rahn; Jasmine Tan-Kim; Donna Mazloomdoost; Marie G Gantz; Holly E Richter
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-01-01       Impact factor: 1.913

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.